Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1086 studies found for:    "Psoriasis"
Show Display Options
Rank Status Study
1 Recruiting MSB11022 in Moderate to Severe Chronic Plaque Psoriasis
Conditions: Psoriasis;   Plaque Type Psoriasis;   Moderate to Severe Plaque Psoriasis
Interventions: Drug: MSB11022;   Drug: Humira®
2 Completed
Has Results
Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis
Intervention: Drug: Etanercept
3 Completed
Has Results
Tofacitinib Ointment For Chronic Plaque Psoriasis
Conditions: Psoriasis Vulgaris;   Psoriasis
Interventions: Drug: tofacitinib ointment 20 mg/g;   Drug: tofacitinib ointment 10 mg/g;   Drug: placebo ointment (vehicle)
4 Completed Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation
Conditions: Psoriasis Vulgaris;   Plaque Psoriasis
Intervention: Drug: Daivobet® Gel
5 Completed A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Drug: 122-0551;   Drug: Vehicle
6 Completed
Has Results
Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis Vulgaris
Interventions: Drug: Taclonex Ointment and Hydrogel Patch;   Drug: Taclonex Ointment
7 Active, not recruiting Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis
Conditions: Chronic Plaque Psoriasis;   Psoriasis
Interventions: Biological: M923;   Biological: Humira
8 Completed
Has Results
Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis
Conditions: Nail Psoriasis;   Plaque Psoriasis
Intervention: Drug: etanercept
9 Completed IL-17 Role in Variants of Psoriasis
Conditions: Scalp Psoriasis;   Pustular Palmo-plantar Psoriasis;   Non-pustular Palmo-plantar Psoriasis;   Elbow Psoriasis;   Lower Leg Psoriasis
Intervention:
10 Completed A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis
Conditions: Nail Psoriasis;   Plaque Psoriasis
Interventions: Biological: Adalimumab (ADA);   Other: Placebo
11 Unknown  Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris
Conditions: Psoriasis;   Psoriasis Vulgaris
Intervention:
12 Recruiting Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Drug: MP1032;   Drug: Placebo
13 Completed
Has Results
A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Drug: Halobetasol Propionate Lotion 0.05%;   Drug: Placebo
14 Active, not recruiting An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Biological: Certolizumab Pegol;   Other: Placebo
15 Recruiting Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis
Interventions: Biological: etanercept;   Biological: etanercept (half dose);   Drug: placebo
16 Active, not recruiting Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Biological: Certolizumab Pegol;   Biological: Etanercept;   Other: Placebo
17 Active, not recruiting A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Biological: Certolizumab Pegol;   Other: Placebo
18 Completed Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Subjects With Moderate-To-Severe Plaque-Type Psoriasis
Conditions: Psoriasis;;   Psoriatic Arthritis;;   Psoriasis Arthropatica
Interventions: Drug: Apremilast;   Drug: Placebo
19 Completed
Has Results
Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis
Conditions: Psoriasis-Type Psoriasis;   Plaque-Type Psoriasis
Intervention: Drug: Apremilast
20 Completed
Has Results
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Conditions: Psoriasis;   Plaque-type Psoriasis
Interventions: Drug: Apremilast 10mg;   Drug: Apremilast 20mg;   Drug: Apremilast 30 mg;   Drug: Placebo;   Drug: Apremilast 30mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years